Rapport Therapeutics Inc.... (RAPP)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
13.44
0.75 (5.91%)
At close: Jan 15, 2025, 12:25 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 |
Net Income | -34.79M | -10.65M |
Depreciation & Amortization | 112.00K | 15.00K |
Stock-Based Compensation | 3.52M | n/a |
Other Working Capital | 1.80M | 1.49M |
Other Non-Cash Items | 1.32M | 5.94M |
Deferred Income Tax | n/a | n/a |
Change in Working Capital | 2.65M | 1.49M |
Operating Cash Flow | -27.18M | -3.24M |
Capital Expenditures | -1.64M | -284.00K |
Acquisitions | n/a | n/a |
Purchase of Investments | -77.22M | n/a |
Sales Maturities Of Investments | n/a | n/a |
Other Investing Acitivies | n/a | -5.00M |
Investing Cash Flow | -78.86M | -5.28M |
Debt Repayment | n/a | 7.90M |
Common Stock Repurchased | -4.00K | n/a |
Dividend Paid | n/a | n/a |
Other Financial Acitivies | 145.09M | n/a |
Financial Cash Flow | 145.14M | 39.69M |
Net Cash Flow | 39.09M | 31.16M |
Free Cash Flow | -28.82M | -3.53M |